This study demonstrates that GBM cells responding to TMZ exert adverse effects by promoting MMP9 activity, and we also propose a mechanism for TMZ-mediated MMP9 regulation, which certainly leads to promoted cancer metastasis from TMZ resistant recurrent GBM. This evidence concerns the gene MMP9 and glioblastoma.